HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparison of clinical and biologic features of Kingella kingae and Staphylococcus aureus arthritis at initial evaluation.

Abstract
We conducted a retrospective study comparing the presenting clinical and biologic features of 64 children who had septic arthritis caused by Kingella kingae with 26 children who had septic arthritis caused by Staphylococcus aureus. Children with K. kingae septic arthritis were significantly younger than those with S. aureus septic arthritis. Otherwise, there were no significant differences between the 2 groups with respect to fever, location, white blood cell count, synovial fluid cell count, C-reactive protein, or serum fibrinogen. However, the clinical course was significantly better for children with septic arthritis caused by K. kingae as evidenced by shorter hospitalization and fewer adverse events. Presumptive antibiotic therapy for septic arthritis in young infants should take into account both of these pathogens, even in case of mild presentation.
AuthorsRomain Basmaci, Mathie Lorrot, Philippe Bidet, Catherine Doit, Christine Vitoux, Georges Penneçot, Keyvan Mazda, Edouard Bingen, Brice Ilharreborde, Stéphane Bonacorsi
JournalThe Pediatric infectious disease journal (Pediatr Infect Dis J) Vol. 30 Issue 10 Pg. 902-4 (Oct 2011) ISSN: 1532-0987 [Electronic] United States
PMID21552181 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Anti-Bacterial Agents
Topics
  • Adolescent
  • Age Factors
  • Anti-Bacterial Agents (therapeutic use)
  • Arthritis, Infectious (microbiology, pathology)
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Infant
  • Kingella kingae (isolation & purification, pathogenicity)
  • Male
  • Neisseriaceae Infections (microbiology, pathology)
  • Retrospective Studies
  • Sex Distribution
  • Staphylococcal Infections (microbiology, pathology)
  • Staphylococcus aureus (isolation & purification, pathogenicity)
  • Time Factors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: